DNLI - Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03 revenue of $42.14M beats by $8.82M
Denali Therapeutics press release (NASDAQ:DNLI): Q1 GAAP EPS of -$0.53 misses by $0.03. Revenue of $42.14M (+432.1% Y/Y) beats by $8.82M.
For further details see:
Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03, revenue of $42.14M beats by $8.82M